A 15-year study of more than 1,600 Australian residents indicates that aspirin may significantly lower the incidence of skin cancer. Aspirin or other non-steroidal anti-inflammatory drugs taken twice a week for more than five years reduced the risk of squamous cell carcinoma by 63 percent. The risk dropped by 90 percent for those taking eight or more tables weekly. The study, conducted by the Queensland Institute of Medical Research and published in the Journal of the American Academy of Dermatology, notes that aspirin appears to block cyclo-oxygenase, an enzyme that is used by cancer cells to stimulate blood cells.

For more information, visit www.yahoo.com.